Kapstone Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Buy
8,968
+393
+5% +$45.4K 0.53% 37
2025
Q4
$903K Buy
8,575
+120
+1% +$11.3K 0.45% 36
2025
Q3
$710K Sell
8,455
-1,047
-11% -$86.2K 0.33% 43
2025
Q2
$752K Buy
9,502
+459
+5% +$36.5K 0.38% 39
2025
Q1
$812K Sell
9,043
-420
-4% -$39.2K 0.46% 36
2024
Q4
$930K Sell
9,463
-433
-4% -$44.6K 0.5% 35
2024
Q3
$1.13M Hold
9,896
0.68% 29
2024
Q2
$1.23M Buy
9,896
+257
+3% +$33.1K 0.8% 28
2024
Q1
$1.27M Sell
9,639
-29
-0.3% -$3.57K 0.87% 25
2023
Q4
$1.16M Buy
9,668
+341
+4% +$35.4K 0.91% 24
2023
Q3
$960K Hold
9,327
0.86% 26
2023
Q2
$982K Buy
9,327
+64
+0.7% +$7.27K 0.81% 26
2023
Q1
$1.07M Hold
9,263
0.97% 22
2022
Q4
$958K Buy
+9,263
New +$947K 0.87% 25

Other funds holding MRK

Kapstone Financial Advisors's MRK Position: Q1 2026 in Review

Kapstone Financial Advisors increased its Merck (MRK) stake by 4.6% in Q1 2026, buying an estimated $45.4K and bringing the position to 8,968 shares worth $1.08M. The position accounts for 0.53% of the portfolio, ranked #37.

Kapstone Financial Advisors first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.27M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Kapstone Financial Advisors held 8,968 shares of Merck worth $1.08M as of Q1 2026.
  • Kapstone Financial Advisors bought 393 Merck shares in Q1 2026, an estimated $45.4K.
  • Merck made up 0.53% of Kapstone Financial Advisors's portfolio in Q1 2026, its #37 holding.
  • Kapstone Financial Advisors first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Kapstone Financial Advisors's Merck position peaked at $1.27M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Kapstone Financial Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.